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 HTLV-1 and HTLV-2 are complex retroviruses which share a similar genomic 
organization but differ in their pathobiology. HTLV-1, the first human retrovirus discovered, 
is the causal agent of an aggressive adult T-cell leukemia, whereas HTLV-2 is associated 
with a few cases of neurological disease. Both virus genomes encode an oncogenic protein, 
Tax, required for viral replication and capable to induce cell transformation. In addition, 
HTLV-1 and -2 generate an antisense transcript, named HBZ and APH-2, respectively, 
crucial for viral infection. Comparative studies between HTLV-1 regulatory proteins, Tax-1 
and HBZ, and the HTLV-2 homologs, Tax-2 and APH-2, may highlight the contribution of 
viral proteins to oncogenesis. 
 The purpose of this study is to investigate the functional role of the viral regulatory 
proteins HBZ and APH-2 in the NF-κB cell signaling, which is constitutively activated by 
Tax in infected cells. We demonstrated that APH-2 and HBZ differ in their suppression of 
the NF-κB promoter activity. Unlike HBZ, the APH-2 protein is recruited by Tax in 
cytoplasmic structures and prevents the degradation of the inhibitor IκB, impairing p65 
nuclear translocation. Furthermore, we found that APH-2, but not HBZ, forms complexes 
with the adaptor protein TRAF3, an upstream inhibitor of the alternative NF-κB pathway. 
We generated a TRAF3-KO cell line applying the CRISPR/Cas9 technique, which will 
allow us to investigate the HBZ and APH-2 role in modulating the alternative NF-κB cell 
signaling. This study may provide insight into the effect of host-viral interactions in human 
viral oncogenesis.  
 
